29 results
8-K
EX-10.1
ICAD
Icad Inc
17 Apr 23
Entry into a Material Definitive Agreement
2:30pm
provides a financial perspective on innovation and profitable growth, leveraging this perspective to improve risk-awareness, strategic decision-making
8-K
EX-99.1
ICAD
Icad Inc
17 Apr 23
Entry into a Material Definitive Agreement
2:30pm
of the Company in this next phase of growth and innovation,” said Mr. Lonnqvist.
Vasu Avadhanula joins as Chief Product Officer
“With a track record … more than 25 years of product development, business analytics, and technology innovation experience in the healthcare and technology industries. Prior
8-K
EX-99.1
hs686hmg1ld4fllfl0xl
21 Apr 22
Company expects preliminary estimated revenue to be $7.5 million
9:53am
8-K
EX-99.1
o56bd2gsf6 qy2
28 Feb 22
Launched ProFound AI® Risk, the world’s first clinical decision support tool for short term breast cancer risk estimation
4:26pm
8-K
EX-99.1
hj750bq 7q2
28 Apr 21
Entry into a Material Definitive Agreement
4:09pm
424B5
azwrsp
4 Mar 21
Prospectus supplement for primary offering
4:23pm
424B5
xn7h8
2 Mar 21
Prospectus supplement for primary offering
4:26pm
8-K
EX-99.1
tzeox 57sbcn
5 Nov 20
Achieved Sequential Revenue Growth of 28% in Third Quarter of 2020, Driven by Detection
4:01pm
8-K
EX-99.1
iox0my39
28 Feb 20
Strong Q4 2019 revenue growth of 35% driven by a 39% increase in revenue from iCAD’s AI Cancer Detection segment
8:32am
8-K
EX-99.1
hb30moq2xvu65
28 Mar 19
Appointment establishes executive infrastructure to enhance strategic and operational momentum and capitalize on significant growth opportunities
5:21pm
8-K
EX-17.1
3t1tpq p1u9r5ww39sj
2 Oct 18
Departure of Directors or Certain Officers
5:21pm